Synergistic Silencing of Skp2 by siRNA Self‐Assembled Nanoparticles as a Therapeutic Strategy for Advanced Prostate Cancer-Reference-Cited by-同舟云学术

Synergistic Silencing of Skp2 by siRNA Self‐Assembled Nanoparticles as a Therapeutic Strategy for Advanced Prostate Cancer

Published:2022-02-19 Issue:14 Volume:18 Page:2106046
ISSN:1613-6810
Container-title:Small
language:en
Short-container-title:Small

Author:

Liang Hong¹²^ORCID,Zhang Fangming¹,Hong Yannv¹,Wu Yue¹,Xie Huanzhang²,Zhang Chen²,Wang Zonghua²,Lu Zhonglei¹^ORCID,Yang Huanghao³^ORCID

Affiliation:

1. College of Biological Science and Engineering Fuzhou University Fuzhou 350108 P. R. China

2. Fujian Key Laboratory of Functional Marine Sensing Materials Fuzhou Institute of Oceanography Minjiang University Fuzhou 350108 P. R. China

3. MOE Key Laboratory for Analytical Science of Food Safety and Biology Fujian Provincial Key Laboratory of Analysis and Detection Technology for Food Safety State Key Laboratory of Photocatalysis on Energy and Environment College of Chemistry Fuzhou University Fuzhou 350108 P. R. China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Biomaterials,Biotechnology,General Materials Science,General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/smll.202106046

Reference69 articles.

1. Cancer Statistics, 2021

2. Efficacy of androgen deprivation therapy (ADT) in patients with advanced prostate cancer

3. Androgen deprivation therapy with chemotherapy or abiraterone for patients with metastatic hormone-naive prostate cancer: a systematic review and meta-analysis